On 27 June 2022, Zhejiang Zhongxin Fluoride Materials Co., Ltd. (002915.SZ) signed the agreement regarding the acquisition of 51% equity interest in Jiangxi Artsen Chemical with a total consideration of RMB 357 million, and the transaction was announced by the company accordingly.
Recently, Grandall Chongqing Office has successfully won the bid for the 2022-2024 perennial legal counsel of Shanghai Pudong Development Bank Chongqing Branch.
On 4 July 2022, OneConnect Financial Technology Co., Ltd. (US.OCFT/HK.06638) was successfully listed on the mainboard of Hong Kong Stock Exchange by way of introduction. Grandall Shanghai has been retained as the Chinese legal counsel of co-sponsors Goldman Sachs and HSBC with YUE Yongping and CHEN Jingyu as key lawyers serving this project.
According to the statics released by China Securities Regulatory Commission (CSRC), Shanghai Stock Exchange, Shenzhen Stock Exchange and Beijing Stock Exchange, 170 companies completed initial public offerings in the first half of 2022, 20 of which, accounting for 11.8% of the total, were advised by Grandall Law Firm, ranking first among law firms, raising nearly RMB 21.3 billion.
In June 2022, a syndicate led by KASIKORNBANK (China) Company Limited, together with Sumitomo Mitsui Banking Corporation (China) Limited, Industrial Bank of Korea (China) Limited, Fubon Hua Yi Bank Limited, and CITIC Bank International (China) Limited, successfully signed a syndicated loan agreement with Haier Consumer Finance Limited for a total amount of RMB 510 million and released the first installment. Grandall Shenzhen Office acted as the legal counsel for this project.
On 22 June 2022, China National Centre of Testing and Inspection for Electric Cable and Wire (“TICW”) successfully listed on the ChiNext Market of Shenzhen Stock Exchange, and Grandall Shanghai Office acted as the legal counsel of the issuer.
On 1 June 2022, Beijing Capital City Development Group Co. Ltd. (“Capital Development”) successfully issued to professional investors the corporate bonds (Phase I of 2022) with an offering size of RMB 2.373 billion. Grandall Beijing Office has been retained as the legal counsel for the issuance with FENG Xiaoyi, ZHOU Liqiong, WANG Yanping, LV Yutong, CHENG Yifan and WANG Yueyao as key lawyers serving the case.
In May 2022, Jiangsu Lopal Tech Co., Ltd. (603906.SH) (“Lopal”) has successfully completed its non-public offering of A shares after the application being passed and approved by China Securities Regulatory Commission on 14 March 2022. Grandall Shanghai has been retained as the legal counsel with ZHANG Zechuan and XIA Binbing as key lawyers serving the case.
China Securities Regulatory Commission. Grandall Chongqing Office has been retained as the issuer’s legal counsel with LI Dong and LEI Meiling leading their team serving the case.
On 13 May 2022, Matrix’s application for the initial public offering and listing on the ChiNext market was passed and approved by the Listing Committee of the ChiNext Market of Shenzhen Stock Exchange. Grandall Shenzhen Office has been retained as the legal counsel for this IPO project with MA Zhuotan and XING Huanghua as key lawyers serving the project.
On 28 March 2022, Shanghai Pharmaceuticals Holding Co., Ltd. (600607.SH/02607.HK) (“SPH”) completed its non-public offering of A shares. The company raised RMB 13.975 billion in this non-public offering, with Yunnan Baiyao (000538.SZ) participating as a strategic investor, marking the refinancing project with the largest amount of funds raised by a listed company as well as the largest amount of funds raised by a listed company in A-share pharmaceutical industry so far.
